NEWSROOM

PRESS RELEASE

BranchOut Food Delivers Shareholder Update: 2024 Revenue Surges 640% in First Half, Poised for Continued Growth and Debt Elimination by Q4 2025

BranchOut Food Delivers Shareholder Update: 2024 Revenue Surges 640% in First Half, Poised for Continued Growth and Debt Elimination by Q4 2025

Aug 28, 2024

BranchOut Food estimated to finish year at $8 million in Net Revenue Net Revenue for 1st half 2024 up over 640% from revenue in 1st half 2023 The Company estimates $5 million in Revenue for 2nd half of 2024, double that of the same period last year, to finish 2024 near $8 million Opening new production facility in Peru with about $40 mm in capacity with first production anticipated in October Completed combined financing of $5.4 million in June and July 2024 to finance completion of new...

BLAQclouds, Inc. Announces Initial Launch of BLAQ Token on BLAQlp.io

BLAQclouds, Inc. Announces Initial Launch of BLAQ Token on BLAQlp.io

Aug 27, 2024

Las Vegas, NV, August 27, 2024 — BLAQclouds, Inc. (OTC: BCDS) is pleased to announce that this week, the company will launch its first liquidity pool partnership on BLAQlp.io with the debut of the BLAQ token on both the Ethereum and ZEUS blockchains. The exact date and time for the launch will be announced with 24 hours prior notice, based on market conditions and other factors. As previously announced, the core smart contract powering BLAQlp.io allows funders to directly contribute to...

Lipella Pharmaceuticals to Participate at H.C. Wainwright’s 26th Annual Global Investment Conference in New York

Lipella Pharmaceuticals to Participate at H.C. Wainwright’s 26th Annual Global Investment Conference in New York

Aug 27, 2024

Company has two lead drug candidates for rare disease indications in IND approved phase 2 clinical trials using the 505(b)(2) pathway Pittsburgh, PA, August 27, 2024 – Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella”) will participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York City at the Lotte New York Palace Hotel on September 9 through 11, 2024. Admission to H.C. Wainwright’s conference is for qualified investors, and Lipella will be giving a virtual...

AmpliTech Group’s AGMDC Division Moves to Allen Tech Hub in Watters Creek District in Allen, Texas

AmpliTech Group’s AGMDC Division Moves to Allen Tech Hub in Watters Creek District in Allen, Texas

Aug 26, 2024

Hauppauge, NY, August 26, 2024 – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced its AmpliTech Group Microwave Design Center move into the prestigious cutting-edge Allen Tech Hub in the heart of...

AB INTL GROUP Announces Repurchase of Common Stock for Cancelation

AB INTL GROUP Announces Repurchase of Common Stock for Cancelation

Aug 26, 2024

NEW YORK, Aug. 26, 2024 - AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced a repurchase of 50,296,980 shares of common stock for cancelation. Its positive cash flow continues to come from net profitability to enable the repurchase of more shares in the near future. On August 21, 2024, AB International Group Corp. (the “Company”) entered into Repurchase Agreements with seven shareholders, all non-affiliates of the...

Halberd Corp. Issues Letter to Shareholders

Halberd Corp. Issues Letter to Shareholders

Aug 26, 2024

JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to its shareholders: Halberd Corp. - Taking a Moment to Recenter Our Technical Progress Introducing Tri-ax™ TBI Nasal Spray Treatment- the DoD selected our MSU-led pre-proposal, inviting us to submit a full application/proposal This is the first of a series of three significant Press Releases we plan to issue shortly. Many of our investors have been voicing...

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

Aug 26, 2024

Successful Conversion Eliminates Over $4 Million in Long-Term Debt New York, NY, August 26, 2024 - ANEW MEDICAL, INC. (NASDAQ: WENA), a leading U.S. biotechnology company pioneering cell and gene-based treatments for aging and age-related diseases, announces the successful conversion of its convertible promissory notes by investors. This strategic move significantly strengthens ANEW’s balance sheet by eliminating over $4 million in long-term debt. The elimination of over $4 million in...

Biofuels Brazil Forum 2024

Biofuels Brazil Forum 2024

Aug 23, 2024

Biofuels Brazil Forum 2024 Date: 27-28 November 2024, Sao Paulo, BrazilOrganizer: Vostock CapitalWebsite "Biofuels Brazil International Investment Forum" is the premier platform for biofuel producers, regulatory bodies, government officials, technology pioneers, equipment suppliers, EPC, engineering companies, and investors from Brazil, Latin America, and Europe. It fosters strategic partnerships and innovation in the biofuels sector, advancing Brazil's leadership in sustainable development...

Foro Biocombustibles Brasil 2024

Foro Biocombustibles Brasil 2024

Aug 23, 2024

Foro Biocombustibles Brasil 2024 Fecha: 27-28 de noviembre de 2024, São Paulo, BrasilOrganizador: Vostock CapitalWebsite El "Foro Internacional de Inversiones en Biocombustibles de Brasil" es la plataforma principal para productores de biocombustibles, organismos reguladores, funcionarios gubernamentales, pioneros tecnológicos, proveedores de equipos, empresas de EPC y de ingeniería, e inversores de Brasil, América Latina y Europa. Fomenta alianzas estratégicas e innovación en el sector de los...

Fórum de Biocombustíveis Brasil 2024

Fórum de Biocombustíveis Brasil 2024

Aug 23, 2024

Fórum de Biocombustíveis Brasil 2024 Data: 27-28 de novembro de 2024, São Paulo, Brasil Organizador: Vostock Capital Website O "Fórum Internacional de Investimentos em Biocombustíveis Brasil" é a principal plataforma para produtores de biocombustíveis, órgãos reguladores, autoridades governamentais, pioneiros em tecnologia, fornecedores de equipamentos, empresas de EPC e engenharia, e investidores do Brasil, América Latina e de outras regiões. O evento promove parcerias...

“Mining Chile and Latin America 2024” in Santiago de Chile

“Mining Chile and Latin America 2024” in Santiago de Chile

Aug 23, 2024

“Mining Chile and Latin America 2024” in Santiago de Chile Meet industry leaders and learn the best practices for the mining sector. Date: October 1st and 2nd 2024 Place: Santiago de Chile Organizer: Vostock Capital Website 5th International Congress and Exhibition Mining Chile and Latin America 2024 brings together, during two days, + 200 decision-makers from national and international companies, + 40 Mining Projects in Chile technology and service providers, and international...

Congreso Internacional y Exhibición “Minería Chile y América Latina 2024″

Congreso Internacional y Exhibición “Minería Chile y América Latina 2024″

Aug 23, 2024

Congreso Internacional y Exhibición “Minería Chile y América Latina 2024" Fecha: 1 y 2 de octubre 2024 Lugar: Santiago de Chile Organizador: Vostock Capital Sitio Web El 5º Congreso y Exhibición Internacional Minería Chile y América Latina 2024 reúne a más de 200 ejecutivos con poder de decisión de empresas nacionales e internacionales, más de 40 proyectos de Mineria en America latina, proveedores de tecnología y servicios, inversionistas internacionales y locales para discutir las principales...

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Aug 22, 2024

Affecting about 6 million Americans, OLP is a chronic inflammatory disease affecting the mucous membranes of the mouth No FDA-approved therapy currently exists for OLP Patient registry and OLP study information is now available Pittsburgh, PA, August 22, 2024 – Lipella Pharmaceuticals, Inc. (NASDAQ: LIPO) has launched an Oral Lichen Planus (OLP) Patient Registry. This online platform is designed to enhance research and drive the development of new treatments for OLP, a chronic inflammatory...

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)

Aug 21, 2024

New York, NY. August 21, 2024 - ANEW MEDICAL, INC. (“ANEW” or the “Company”) (NASDAQ: WENA), announced the signing of an exclusive worldwide license agreement with Transfertech Sherbrooke(“TTS”)regarding Nanoject, a needle-free, freeze-dried nanopowder autoinjector for medicines and vaccines. Needle phobia and injection or blood-drawing anxiety are prevalent among adults and children, creating barriers to adhering to doctor visits and medication protocols. Alternatives to needle/syringes have...

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference

Aug 21, 2024

LP-20 contrast agent designed to diagnose interstitial cystitis and detect bladder cancer Novel MRI contrast agent, which received support from National Institute of Diabetes and Digestive and Kidney Diseases 5th International Consultation on Interstitial Cystitis Japan runs Aug. 21-23 in Kyoto Pittsburgh, PA, August 21, 2024 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotech company, will highlight clinical data on LP-20, a novel MRI contrast agent designed for diagnosing...

AB INTL GROUP Announces Repurchase of Common Stock for Cancelation

AB INTL GROUP Announces Business Updates

Aug 20, 2024

NEW YORK, August 20, 2024 -- AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced business updates. Achieved net profitability in latest quarter ending on May 31, 2024. **Financial Performance**: - Recent financial reports indicate a focus on increasing revenues while reducing expenses, leading to net profitability. For the period ending May 31, 2024, the Company reported a significant increase in revenue and a...

Ethical Web AI announces that its Ethical Web product is now demonstrable

Ethical Web AI announces that its Ethical Web product is now demonstrable

Aug 19, 2024

NEW YORK, August 19, 2024 – Bubblr Inc., d/b/a Ethical Web AI (OTC: BBLR) - a frontrunner in ethical technology determined to revolutionize the digital domain, has announced that its Ethical Web product is now demonstrable. The Ethical Web platform has been in development for over three years. It is the technical manifestation of its highly valued granted US patent 10977387. Established internet search engines have not really changed in over 30 years. This new platform allows licensees to...

SKYX to Collaborate with EGLO, European World Leading Design and Manufacturer of Decorative Lighting and Ceiling Fans

SKYX to Collaborate with EGLO, European World Leading Design and Manufacturer of Decorative Lighting and Ceiling Fans

Aug 19, 2024

The Collaboration Provides for the Joint Exploration and Product Development Potential for European and International markets for leveraging SKYX’s Technology, Product and Manufacturing Expertise of the Two Companies MIAMI, FL, August 19, 2024 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the "Company" or "SKYX"), a highly disruptive smart platform technology company with more than 97 issued and pending patents globally and over 60 lighting and home décor websites, announces...

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Appoints New CFO

Aug 19, 2024

New York, NY, August 19, 2024 - ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a U.S.-based biotechnology company focused on developing cell and gene-based treatments for aging, and age-related diseases, today announced the appointment of Jeffrey LeBlanc as the company’s Chief Financial Officer (CFO), replacing the interim CFO, Edward Cong Wang who was the former CFO of Redwoods Acquisition Corp into which ANEW merged. “Jeff LeBlanc is a highly experienced senior executive, and we...

Sono-Tek to Present at August 20th Virtual Investor Summit Microcap Event

Sono-Tek to Present at August 20th Virtual Investor Summit Microcap Event

Aug 15, 2024

MILTON, NY, August 15, 2024 — Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of ultrasonic coating systems, announced today that it will be presenting at the upcoming Virtual Investor Summit on August 20, 2024. Investors may request a one-on-one meeting with management by registering here: https://investorsummitgroup.com. Event: Q3 Investor SummitDate: August 20, 2024Presentation Time: 1:30 PM ETLocation: https://www.webcaster4.com/Webcast/Page/3062/51124 About...

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases

Aug 15, 2024

Issuance of the Klotho gene-therapy patent will be instrumental in protecting ANEW’s IP for development and commercialization in the U.S. New York, NY, August 15, 2024 - ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA), a U.S.-based biotechnology company focused on developing cell and gene-based treatments for aging and age-related diseases; today announced the grant and issuance of U.S. Patent No. 12,036,268 (“the 268 patent”) covering the secreted RNA splice variant of the human...

AmpliTech Group’s AGMDC Division Moves to Allen Tech Hub in Watters Creek District in Allen, Texas

AmpliTech Group Reports Q2 Revenue of $2.5M with 1.05M Gross Profits and 42% Gross Margins

Aug 14, 2024

Hauppauge, NY, August 14, 2024 – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced its financial results for the second quarter ended June 30, 2024. The company plans to host an investor call within...

American Shared Hospital Services Reports Strong Second Quarter 2024 Financial Results

American Shared Hospital Services Reports Strong Second Quarter 2024 Financial Results

Aug 14, 2024

Revenue increases 27% year over year Reports gain of $3.7 million from strategic acquisition of Rhode Island Radiation Therapy Cancer Centers Now treating patients at the new Puebla, Mexico center Conference Call on August 14th at 6:30 pm ET SAN FRANCISCO, CA, August 14, 2024 ‒ American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and...

American Shared Hospital Services Reports Strong Second Quarter 2024 Financial Results

American Shared Hospital Services Announces Second Quarter 2024 Earnings Conference Call

Aug 14, 2024

Call Scheduled for Today at 6:30 PM ET SAN FRANCISCO, August 14, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a conference call to discuss its second quarter 2024 financial results today, August 14th at 6:30 pm ET / 3:30 pm PT. The second quarter 2024 financial results press release...

Sono-Tek to Present at August 20th Virtual Investor Summit Microcap Event

Sono-Tek Announces Additional $2.95 Million Order from Specialty Clean Energy Customer

Aug 13, 2024

4 System Order Expected to be Shipped in Fiscal 2026 Company Experiencing Strong Demand from Clean Energy Sector MILTON, NY, August 13, 2024 — Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of ultrasonic coating systems, is pleased to announce the receipt of an additional $2.95 million order from an existing clean energy customer. This new order, identical in value and scope to a recent record-breaking order from the same customer, reinforces Sono-Tek’s position as a...

BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million

BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million

Aug 12, 2024

Company reports transformative second-quarter revenue, contributing to a record total of $116.4 million in revenue for the first half of 2024 AmnioWrap2 continues to be a major growth driver achieving an impressive 56.5% sequential revenue increase compared to Q1 2024 Achieves second consecutive quarter of positive net income with $6.3 million Generated Adjusted Q2 2024 EBITDA of $10.0 million Financial Results Conference Call and Webcast on Monday, August 12, 2024, at 4:30 pm EDT POMPANO...

SKYX to Collaborate with EGLO, European World Leading Design and Manufacturer of Decorative Lighting and Ceiling Fans

SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products

Aug 12, 2024

MIAMI, FL, August 12, 2024 – SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with over 97 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today reported its financial and operational results for the second quarter ended June 30, 2024. Second Quarter 2024 and Recent Achievements Generated...

AB INTL GROUP Announces Repurchase of Common Stock for Cancelation

AB INTL GROUP Reports of Financial Results for period ending May 31, 2024 and achieved Net Profitability

Aug 12, 2024

NEW YORK, August 12, 2024 -- AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, announces its financial results for the period ended May 31, 2024. The financial results have been filed in a 10-Q with the U.S. Securities and Exchange Commission (the "SEC"). Key Financial Highlights: Revenues for the three months ended May 31, 2024, increased 22% to $698,311, as compared to $573,389 for the three months ended May 31, 2023. Net income...

StemSation International Provides Corporate Updates

StemSation International Provides Corporate Updates

Aug 12, 2024

StemSation International is providing updates on corporate planning and direction as they execute on an expanded business model Plantation, Florida, August 12, 2024 – StemSation International (OTC: STSN), a South-Florida based company that has licensed technology for the production and distribution of flavored, canned oxygen products is announcing new business initiatives for the upcoming months. "We announced last year that we had streamlined our current business and would be seeking further...

Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

Aug 12, 2024

Top Line Data Expected Year-End 2024 Pittsburgh, August 12, 2024 -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” “we” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces the dosing of the first two patients with LP-310 in its Phase 2a clinical trial in Oral Lichen Planus (OLP) patients. Lipella’s Phase 2a trial is a multicenter, dose-ranging study involving adult male and female subjects...